These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3207603)

  • 1. Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres.
    Wagstaff J; Gregory WM; Swindell R; Crowther D; Lister TA
    Br J Cancer; 1988 Oct; 58(4):487-92. PubMed ID: 3207603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP.
    Ranson MR; Radford JA; Swindell R; Deakin DP; Wilkinson PM; Harris M; Johnson RJ; Crowther D
    Ann Oncol; 1991 Jun; 2(6):423-9. PubMed ID: 1768629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechlorethamine, vinblastine, procarbazine and prednisolone (MVPP) for advanced Hodgkin's disease.
    Harding MJ; McNulty LJ; Paul J; Lee F; Brown A; Soukop M
    Eur J Cancer; 1991; 27(8):1002-6. PubMed ID: 1832882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of stage IIIA Hodgkin's disease.
    Lister TA; Dorreen MS; Faux M; Jones AE; Wrigley PF
    J Clin Oncol; 1983 Dec; 1(12):745-9. PubMed ID: 6689424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.
    Oza AM; Ganesan TS; Dorreen M; Johnson PW; Waxman J; Gregory W; Lim J; Wright J; Dadiotis L; Barbounis V
    Br J Cancer; 1992 Mar; 65(3):429-37. PubMed ID: 1558800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
    Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
    J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.
    Anderson H; Deakin DP; Wagstaff J; Jones JM; Todd ID; Wilkinson PM; James RD; Steward WP; Blackledge G; Scarffe JH
    Br J Cancer; 1984 Jun; 49(6):695-702. PubMed ID: 6375711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.
    Crowther D; Wagstaff J; Deakin D; Todd I; Wilkinson P; Anderson H; Blackledge G; Jones M; Scarffe JH
    J Clin Oncol; 1984 Aug; 2(8):892-7. PubMed ID: 6379122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children: long-term results.
    Armata J; Borkowski W; Depowska T
    Am J Pediatr Hematol Oncol; 1984; 6(4):462-5. PubMed ID: 6549497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
    Brusamolino E; Orlandi E; Morra E; Castelli G; Pagnucco G; Livraghi A; Astori C; Santagostino A; Lazzarino M; Bernasconi C
    Ann Oncol; 1994; 5 Suppl 2():53-7. PubMed ID: 7515648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of localized, infradiaphragmatic Hodgkin's disease: experience of a rare clinical presentation at St Bartholomew's Hospital.
    Dorreen MS; Wrigley PF; Jones AE; Shand WS; Stansfeld AG; Lister TA
    Hematol Oncol; 1984; 2(4):349-57. PubMed ID: 6441766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease of the liver; prognosis and possible indications for radiotherapy.
    O'Brien P; Crow J; Brada M; Ashley S; Horwich A
    Clin Oncol (R Coll Radiol); 1991 Jul; 3(4):189-92. PubMed ID: 1931760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.
    Raemaekers J; Burgers M; Henry-Amar M; Pinna A; Mandard A; Monfardini S; Hagenbeek A; Breed W; Carde P; Vovk M; van Hoof A; Thomas J; Noordijk E
    Ann Oncol; 1997; 8 Suppl 1():111-4. PubMed ID: 9187443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
    Hutchinson RJ; Fryer CJ; Davis PC; Nachman J; Krailo MD; O'Brien RT; Collins RD; Whalen T; Reardon D; Trigg ME; Gilchrist GS
    J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Group d'Etudes des Lymphomes de l'Adulte Study.
    Fermé C; Bastion Y; Brice P; Lederlin P; Diviné M; Gabarre J; Assouline D; Ferrant A; Berger F; Lepage E
    Cancer; 1997 Sep; 80(6):1124-33. PubMed ID: 9305714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
    Straus DJ; Gaynor JJ; Myers J; Merke DP; Caravelli J; Chapman D; Yahalom J; Clarkson BD
    J Clin Oncol; 1990 Jul; 8(7):1173-86. PubMed ID: 1694235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
    Silingardi V; Federico M; Frassoldati A; Barbieri F; Palomba G; Mauri C
    Acta Haematol; 1989; 82(4):179-86. PubMed ID: 2511719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal BG; Marcus R; Brecher M; Ternberg J; Behm FG; Cantor A; Wharam M; Chauvenet A
    J Clin Oncol; 1991 Sep; 9(9):1591-8. PubMed ID: 1714950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.